The Footprints of Winter

By Ralf Müller and Justin Goodrich The Footprints of Winter Epigenetic marks laid down during the cold months of the year allow flowering in spring and summer. Iain Sarjeant / ISTOCKIPHOTO.COM Many plants that grow in climates with a cold winter require growth for several months at low temperatures—a process called vernalization—to promote flowering in spring, when days lengthen and temperatures increase. Without this period of cold, plants wo

Written byRalf Muller and Justin Goodrich
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Many plants that grow in climates with a cold winter require growth for several months at low temperatures—a process called vernalization—to promote flowering in spring, when days lengthen and temperatures increase. Without this period of cold, plants would grow leaves in the spring, but would fail to flower. This phenomenon, familiar to every horticulturist, was difficult to explain with genetics alone; something occurred during those cold months that left a mark, which, in effect, released a switch that permitted flowering in spring. In recent years, the field has looked beyond the genome and found that vernalization is controlled by a wide range of epigenetic mechanisms.

Researchers studying the genetics of flowering found that the flowering switch was controlled by two central players—the genes FLOWERING LOCUS T (FT) and SUPPRESSOR OF CONSTANS1 (SOC1), which were held in the “off” position by the product of the gene called FLOWERING LOCUS C (FLC).1 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies